{"url":"https://lda.senate.gov/api/v1/filings/700bf9e7-7990-409d-9bef-e8f341f1c15f/","filing_uuid":"700bf9e7-7990-409d-9bef-e8f341f1c15f","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2022,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/700bf9e7-7990-409d-9bef-e8f341f1c15f/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Gregg Harper","dt_posted":"2022-07-13T20:29:39-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 East Capitol Street","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Jackson","registrant_state":"MS","registrant_zip":"39201","registrant":{"id":401104403,"url":"https://lda.senate.gov/api/v1/registrants/401104403/","house_registrant_id":null,"name":"WATKINS & EAGER PLLC","description":"law firm","address_1":"400 East Capitol Street","address_2":null,"address_3":null,"address_4":null,"city":"Jackson","state":"MS","state_display":"Mississippi","zip":"39201","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GREGG HARPER","contact_telephone":"+1 601-291-6839","dt_updated":"2025-06-07T13:43:12.171888-04:00"},"client":{"id":206871,"url":"https://lda.senate.gov/api/v1/clients/206871/","client_id":101,"name":"ZYNERBA PHARMACEUTICALS, INC.","general_description":"health/governmental assistance before FDA","client_government_entity":false,"client_self_select":null,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2020-09-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Encourage Members to act favorably on matters of importance to Zynerba at their direction; trial for medication that could help individuals with fragile x syndrome.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":79398,"prefix":null,"prefix_display":null,"first_name":"GREGG","nickname":null,"middle_name":"L","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":"Former Member of U.S. House of Representatives","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"GOV","general_issue_code_display":"Government Issues","description":"Set up meetings or calls with Members for Zynerba when necessary; Help in identifying Testing Sites; working with UMMC physicians on the trail study.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":79398,"prefix":null,"prefix_display":null,"first_name":"GREGG","nickname":null,"middle_name":"L","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":"Former Member of U.S. House of Representatives","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Providing services on behalf of Zynerba to the pharmaceutical industry - looking for testing sites","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":79398,"prefix":null,"prefix_display":null,"first_name":"GREGG","nickname":null,"middle_name":"L","last_name":"HARPER","suffix":null,"suffix_display":null},"covered_position":"Former Member of U.S. House of Representatives","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}